245 related articles for article (PubMed ID: 31587361)
1. In silico design and molecular basis for the selectivity of Olinone toward the first over the second bromodomain of BRD4.
Rodríguez Y; Gerona-Navarro G; Osman R; Zhou MM
Proteins; 2020 Mar; 88(3):414-430. PubMed ID: 31587361
[TBL] [Abstract][Full Text] [Related]
2. Discovery and characterization of bromodomain 2-specific inhibitors of BRDT.
Yu Z; Ku AF; Anglin JL; Sharma R; Ucisik MN; Faver JC; Li F; Nyshadham P; Simmons N; Sharma KL; Nagarajan S; Riehle K; Kaur G; Sankaran B; Storl-Desmond M; Palmer SS; Young DW; Kim C; Matzuk MM
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33637650
[TBL] [Abstract][Full Text] [Related]
3. Revealing binding selectivity of inhibitors toward bromodomain-containing proteins 2 and 4 using multiple short molecular dynamics simulations and free energy analyses.
Wang LF; Wang Y; Yang ZY; Zhao J; Sun HB; Wu SL
SAR QSAR Environ Res; 2020 May; 31(5):373-398. PubMed ID: 32496901
[TBL] [Abstract][Full Text] [Related]
4. Structure investigation, enrichment analysis and structure-based repurposing of FDA-approved drugs as inhibitors of BET-BRD4.
Wakchaure P; Velayutham R; Roy KK
J Biomol Struct Dyn; 2019 Aug; 37(12):3048-3057. PubMed ID: 30079805
[TBL] [Abstract][Full Text] [Related]
5. Computational study on the selective inhibition mechanism of MS402 to the first and second bromodomains of BRD4.
Wang Q; Li Y; Xu J; Wang Y; Shi D; Liu L; Leung EL; Yao X
Proteins; 2019 Jan; 87(1):3-11. PubMed ID: 30260047
[TBL] [Abstract][Full Text] [Related]
6. Molecular docking and dynamics simulation study of flavonoids as BET bromodomain inhibitors.
Raj U; Kumar H; Varadwaj PK
J Biomol Struct Dyn; 2017 Aug; 35(11):2351-2362. PubMed ID: 27494802
[TBL] [Abstract][Full Text] [Related]
7. In silico study directed towards identification of novel high-affinity inhibitors targeting an oncogenic protein: BRD4-BD1.
Tumdam R; Kumar A; Subbarao N; Balaji BS
SAR QSAR Environ Res; 2018 Dec; 29(12):975-996. PubMed ID: 30411639
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a hidden transient state in all bromodomain families.
Raich L; Meier K; Günther J; Christ CD; Noé F; Olsson S
Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33468647
[TBL] [Abstract][Full Text] [Related]
9. A computational insight into binding modes of inhibitors XD29, XD35, and XD28 to bromodomain-containing protein 4 based on molecular dynamics simulations.
Su J; Liu X; Zhang S; Yan F; Zhang Q; Chen J
J Biomol Struct Dyn; 2018 Apr; 36(5):1212-1224. PubMed ID: 28466681
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition mechanism of RVX-208 to the second bromodomain of bromo and extraterminal proteins: insight from microsecond molecular dynamics simulations.
Wang Q; Li Y; Xu J; Wang Y; Leung EL; Liu L; Yao X
Sci Rep; 2017 Aug; 7(1):8857. PubMed ID: 28821780
[TBL] [Abstract][Full Text] [Related]
11. Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding Sites.
Olp MD; Sprague DJ; Goetz CJ; Kathman SG; Wynia-Smith SL; Shishodia S; Summers SB; Xu Z; Statsyuk AV; Smith BC
ACS Chem Biol; 2020 Apr; 15(4):1036-1049. PubMed ID: 32149490
[TBL] [Abstract][Full Text] [Related]
12. Binding Mechanism of Inhibitors to BRD4 and BRD9 Decoded by Multiple Independent Molecular Dynamics Simulations and Deep Learning.
Wang J; Yang W; Zhao L; Wei B; Chen J
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675678
[TBL] [Abstract][Full Text] [Related]
13. Binding pocket-based design, synthesis and biological evaluation of novel selective BRD4-BD1 inhibitors.
Ma J; Chen H; Yang J; Yu Z; Huang P; Yang H; Zheng B; Liu R; Li Q; Hu G; Chen Z
Bioorg Med Chem; 2019 May; 27(9):1871-1881. PubMed ID: 30926312
[TBL] [Abstract][Full Text] [Related]
14. Theoretically exploring selective-binding mechanisms of BRD4 through integrative computational approaches.
Luo D; Tong JB; Xiao XC; Bian S; Zhang X; Wang J; Xu HY
SAR QSAR Environ Res; 2021 Dec; 32(12):985-1011. PubMed ID: 34845959
[TBL] [Abstract][Full Text] [Related]
15. Probing molecular mechanism of inhibitor bindings to bromodomain-containing protein 4 based on molecular dynamics simulations and principal component analysis.
Wu SL; Wang LF; Sun HB; Wang W; Yu YX
SAR QSAR Environ Res; 2020 Jul; 31(7):547-570. PubMed ID: 32657160
[TBL] [Abstract][Full Text] [Related]
16. Insight into selective mechanism of class of I-BRD9 inhibitors toward BRD9 based on molecular dynamics simulations.
Su J; Liu X; Zhang S; Yan F; Zhang Q; Chen J
Chem Biol Drug Des; 2019 Feb; 93(2):163-176. PubMed ID: 30225973
[TBL] [Abstract][Full Text] [Related]
17. Binding Kinetics versus Affinities in BRD4 Inhibition.
Kuang M; Zhou J; Wang L; Liu Z; Guo J; Wu R
J Chem Inf Model; 2015 Sep; 55(9):1926-35. PubMed ID: 26263125
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and elaboration of N-methylpyrrolidone as an acetamide fragment substitute in bromodomain inhibition.
Hilton-Proctor JP; Ilyichova O; Zheng Z; Jennings IG; Johnstone RW; Shortt J; Mountford SJ; Scanlon MJ; Thompson PE
Bioorg Med Chem; 2019 Dec; 27(24):115157. PubMed ID: 31727451
[TBL] [Abstract][Full Text] [Related]
19. Structural and thermodynamic characterization of the binding of isoliquiritigenin to the first bromodomain of BRD4.
Yokoyama T; Matsumoto K; Ostermann A; Schrader TE; Nabeshima Y; Mizuguchi M
FEBS J; 2019 May; 286(9):1656-1667. PubMed ID: 30565859
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel BRD4-BD2 inhibitors via in silico approaches: QSAR techniques, molecular docking, and molecular dynamics simulations.
Tong JB; Xiao XC; Luo D; Xu HY; Xing YC; Gao P; Liu Y
Mol Divers; 2024 Apr; 28(2):671-692. PubMed ID: 36773087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
